Radiation Oncology Journal
- 제11권2호
- /
- Pages.295-301
- /
- 1993
- /
- 2234-1900(pISSN)
- /
- 2234-3156(eISSN)
절제 불가능한 제 3 기 비소세포 폐암의 MVP 복합 항암요법과 다분할 방사선 치료 -추가 항암요법에 대한 임의 선택 -
Hyperfractionated Radiotherapy Following Induction Chemotherapy for Stage III Non-Small Cell Lung Cancer -Randomized for Adjuvant Chemotherapy vs. Observation-
- 최은경 (울산대학교 의과대학, 서울중앙병원 치료방사선과학교실) ;
- 장혜숙 (울산대학교 의과대학, 서울중앙병원 치료방사선과학교실) ;
- 안승도 (울산대학교 의과대학, 서울중앙병원 치료방사선과학교실) ;
- 양광모 (울산대학교 의과대학, 서울중앙병원 치료방사선과학교실) ;
- 서철원 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 이규형 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 이정신 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 김상희 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 고윤석 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 김우성 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 김원동 (울산대학교 의과대학, 서울중앙병원 내과학교실) ;
- 송군식 (울산대학교 의과대학, 서울중앙병원 진단방사선과학교실) ;
- 손광현 (울산대학교 의과대학, 서울중앙병원 흉부외과학교실)
- Choi, Eun-Kyung (Department of Therapeutic Radiology, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Chang, Hye-Sook (Department of Therapeutic Radiology, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Ahn, Seung-Do (Department of Therapeutic Radiology, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Yang, Kwang-Mo (Department of Therapeutic Radiology, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Suh, Cheol-Won (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Lee, Kyoo-Hyung (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Lee, Jung, Shin (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Kim, Sang-Hee (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Ko, Youn-Suk (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Kim, Woo-Sung (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Kim, Won-Dong (Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Song, Koun-Sik (Department of Diagnostic Radiology, Asan Medical Center, College of Medicine, University of Ulsan) ;
- Sohn, Kwang-Hyun (Department of Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan)
- 발행 : 1993.12.01
초록
절제 불가능한 제 3기 비소세포 폐암에서의 MVP(Mitomycin C 6
Since Jan. 1991 a prospective randomized study for Stage III unresectable non small cell lung cancer (NSCLC) has been conducted to evaluate the response rate and tolerance of induction chemotherapy with MVP followed by hyperfractionated radiotherapy and evaluate the efficacy of maintenance chemotherapy in Asan Medical Center. All patients in this study were treated with hyperfractionated radiotherapy (120 cGy/fx BID, 6480 cGy/54 fx) following 3 cycles of induction chemotherapy, MVP (Mitomycin C 6